{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        577, 
        591
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1276, 
        1292
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1144, 
        1152
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        532, 
        547
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        686, 
        701
      ]
    }
  ], 
  "Neoplasm Grade-Score Name (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        593, 
        600
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 9^9999^MOH|PIMS|CCO|20160504235554|8E5E3F25058D009336038E9DC2218C0B6D3D0671|ORU^R01|999999999999|P|2.5||||||\nPID|1||N999999999^^^^CMR^HOSPITAL 9&9999&MOH~N999999999^^^^MRN^HOSPITAL 9&9999&MOH~9999999999&LY&ON^^^^JHN||XXXXXXX^XXXXXXXX^ ^^^^||99999999|M|||99 XXXXXXXXXXXX XX^^XXXXXXXX^XX^X9X 9X9^999|||||||||||||||||||N|||\nOBR|1||S16-10759|11529-5^Surgical Pathology Study Report^LN^P^Pathology^L|||20160427|||65206^XXXXXXX^XXXXX^^^^||||||||||||20160504|||F|||||||99999^XXXXXXXXX^XXXXX^^^^|||||||\n\n\n\n\n\n\n\nFINAL DIAGNOSIS\n\nPROSTATE, CURETTINGS:\n   -  ADENOCARCINOMA, GLEASON GRADE 7/10 (3,4) PRESENT IN 40-50% OF THE\n     CURETTINGS.\n               (CODE 1)\n\n\nGROSS PATHOLOGY\n\nThe specimen is received in formalin, labelled with the patient's name and as \"prostate chips\". The specimen consists of multiple irregularly\nshaped fragments of tan-brown, friable tissue measuring up to 6.0 x 5.0 x 1.0 cm in\naggregate and weighing 12.0 gm in toto. The largest fragment measures 2.0 x 0.3 x\n0.2 cm. The specimen is submitted entirely in cassettes A1 to A5 (largest fragment\nin A1).                                     /ET\n\n\nCOMMENTS\n\nSpecimen: A\nExcision time: 1118\nTime placed in Formalin: 1118\n\n\nTISSUE SUBMITTED\n\nPROSTATE CURETTINGS (PROSTATE CHIPS )\n\n\nCLINICAL HISTORY\n\nBPH\n\n\n"
}